Chris M. Ireland
- Biotechnology top 0.05%
- Marine Sponges and Natural Products 70
- Pharmacology top 0.2%
- Microbial Natural Products and Biosynthesis 33
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents 10
- Organic Chemistry top 0.5%
- Synthetic Organic Chemistry Methods 18
- Chemical synthesis and alkaloids 10
- Cancer Research top 2%
- Synthesis and Biological Activity 36
-
- Chemical Synthesis and Analysis 13
- Cancer therapeutics and mechanisms 8
- Co-authors
- Tim S. BugniLouis R. BarrowsMary Kay HarperPaul J. ScheuerTadeusz F. MolinskiD. John FaulknerGisela P. ConcepciónRyan M. Van Wagoner
- Cited by
- BiotechnologyPharmacologyToxicology
- Journals
- Science (2 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of the American Chemical Society (7 papers)
- Partner nations
- United StatesPhilippinesTürkiye
In The Last Decade
Chris M. Ireland
140 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Biotechnology 2.5k
- Pharmacology 2.0k
- Toxicology 343
- Organic Chemistry 2.1k
- Cancer Research 720
Countries citing papers authored by Chris M. Ireland
This map shows the geographic impact of Chris M. Ireland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris M. Ireland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris M. Ireland more than expected).
Fields of papers citing papers by Chris M. Ireland
This network shows the impact of papers produced by Chris M. Ireland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris M. Ireland. The network helps show where Chris M. Ireland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chris M. Ireland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2018 | 75 | |
| 3 | 2017 | 65 | |
| 4 | 2013 | 18 | |
| 5 | 2013 | 16 | |
| 6 | 2011 | 20 | |
| 7 | 2011 | 13 | |
| 8 | 2010 | 11 | |
| 9 | 2009 | 12 | |
| 10 | 2009 | 17 | |
| 11 | 2008 | 38 | |
| 12 | 2008 | 74 | |
| 13 | 2006 | 58 | |
| 14 | 2006 | 38 | |
| 15 | 2005 | 30 | |
| 16 | 2004 | 59 | |
| 17 | 2003 | 18 | |
| 18 | Phenylethanoid glycosides from Scutellaria galericulata | 2002 | 16 |
| 19 | 1994 | 10 | |
| 20 | 1989 | 23 |
About Chris M. Ireland
Chris M. Ireland is a scholar working on Biotechnology, Toxicology and Cancer Research, having authored 140 papers that have together received 5.9k indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (70 papers), Synthesis and Biological Activity (36 papers), Microbial Natural Products and Biosynthesis (33 papers), Synthetic Organic Chemistry Methods (18 papers), Chemical Synthesis and Analysis (13 papers), Bioactive Compounds and Antitumor Agents (10 papers), Chemical synthesis and alkaloids (10 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Biotechnology (2.5k citations), Pharmacology (2.0k citations) and Toxicology (343 citations). Chris M. Ireland has collaborated with scholars based in United States, Philippines and Türkiye. Frequent co-authors include Tim S. Bugni, Louis R. Barrows, Mary Kay Harper, Paul J. Scheuer, Tadeusz F. Molinski, D. John Faulkner, Gisela P. Concepción, Ryan M. Van Wagoner, Jon Clardy and Deniz Taşdemir. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.